{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:42:03Z","timestamp":1762101723363,"version":"3.40.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Wu Jieping Medical Fund","award":["320.6750.12224"],"award-info":[{"award-number":["320.6750.12224"]}]},{"name":"Doctoral Program of Higher Education","award":["20110181120037"],"award-info":[{"award-number":["20110181120037"]}]},{"name":"SiChuan province science and technology","award":["2014SZ0008"],"award-info":[{"award-number":["2014SZ0008"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.jocn.2015.01.025","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T19:34:38Z","timestamp":1433619278000},"page":"1227-1231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The efficacy of levetiracetam for patients with supratentorial brain tumors"],"prefix":"10.1016","volume":"22","author":[{"given":"Yang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Peizhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gou","family":"Maling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Yunhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-7350","authenticated-orcid":false,"given":"Mao","family":"Qing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Yanhui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Ruofei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo","family":"Jiewen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2015.01.025_b0005","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/s10072-005-0404-y","article-title":"Brain tumoral epilepsy: a review","volume":"26","author":"Riva","year":"2005","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jocn.2015.01.025_b0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1212\/01.wnl.0000324624.52935.46","article-title":"Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery","volume":"71","author":"Milligan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2015.01.025_b0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2015.01.025_b0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-010-0126-8","article-title":"A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures","volume":"99","author":"Usery","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2015.01.025_b0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0028-3886.111118","article-title":"A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas","volume":"61","author":"Garbossa","year":"2013","journal-title":"Neurol India"},{"key":"10.1016\/j.jocn.2015.01.025_b0030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Kerkhof","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2015.01.025_b0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneurol.2009.335","article-title":"Efficacy and safety of levetiracetam in patients with glioma","volume":"67","author":"Rosati","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2015.01.025_b0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00701-011-1144-9","article-title":"Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial","volume":"154","author":"B\u00e4hr","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.jocn.2015.01.025_b0120","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/neuonc\/not170","article-title":"Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study","volume":"16","author":"Rossetti","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2015.01.025_b0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/02688697.2011.638996","article-title":"Effect of valproic acid on the outcome of glioblastoma multiforme","volume":"26","author":"Tsai","year":"2012","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.jocn.2015.01.025_b0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jocn.2011.07.021","article-title":"Levetiracetam compared to phenytoin for the prevention of postoperative seizures after craniotomy for intracranial tumours in patients without epilepsy","volume":"19","author":"Kern","year":"2012","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2015.01.025_b0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-010-0460-x","article-title":"Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life","volume":"104","author":"Maschio","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2015.01.025_b0060","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/1793-5482.125658","article-title":"Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures","volume":"8","author":"Gokhale","year":"2013","journal-title":"Asian J Neurosurg"},{"key":"10.1016\/j.jocn.2015.01.025_b0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-006-9162-9","article-title":"Levetiracetam therapy in patients with brain tumour and epilepsy","volume":"80","author":"Maschio","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2015.01.025_b0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S1059-1311(03)00096-7","article-title":"Levetiracetam: preliminary experience in patients with primary brain tumours","volume":"12","author":"Wagner","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.jocn.2015.01.025_b0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11060-010-0235-4","article-title":"Postoperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery","volume":"101","author":"Zachenhofer","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2015.01.025_b0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10072-009-0087-x","article-title":"Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study","volume":"30","author":"Dinapoli","year":"2009","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jocn.2015.01.025_b0085","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11060-008-9781-4","article-title":"Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study","volume":"93","author":"Lim","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2015.01.025_b0090","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","article-title":"Seizure prognosis in brain tumors: new insights and evidence-based management","volume":"19","author":"Vecht","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.jocn.2015.01.025_b0095","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/jns.1983.58.5.0672","article-title":"Phenytoin and postoperative epilepsy. A double-blind study","volume":"58","author":"North","year":"1983","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2015.01.025_b0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/014107689108400412","article-title":"Epilepsy after craniotomy and the place of prophylactic anticonvulsant drugs: discussion paper","volume":"84","author":"Shaw","year":"1991","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jocn.2015.01.025_b0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11060-006-9229-7","article-title":"Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine","volume":"81","author":"Mauro","year":"2007","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.jocn.2015.01.025_b0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0920-1211(01)00287-X","article-title":"Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review","volume":"46","author":"Marson","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jocn.2015.01.025_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/WNF.0b013e31806ad6cb","article-title":"Cutaneous drug eruptions by current antiepileptics: case reports and alternative treatment options","volume":"31","author":"Sahin","year":"2008","journal-title":"Clin Neuropharmacol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815000971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815000971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T05:30:38Z","timestamp":1566797438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586815000971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0967586815000971"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2015.01.025","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of levetiracetam for patients with supratentorial brain tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2015.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}